The potential applications of Apolipoprotein E in personalized medicine.

Front Aging Neurosci · 2014 · PMC4085650 · PMID 25071563

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

study showed a trend toward higher dosage when compared to the other genotypes, which might have resulted in more severe side effects (Maitland-Van Der Zee et al., 2003 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.